Template:High density lipoprotein: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 3: Line 3:
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |


'''High density lipoprotein Microchapters
'''High density lipoprotein Microchapters'''
'''
|- bgcolor="LightGrey"
|- bgcolor="LightGrey"
!
!
|- bgcolor="LightCoral"
|- bgcolor="LightCoral"
!
!
Line 12: Line 12:
|-  
|-  
!
!
|- bgcolor="Pink"
!
[[High density lipoprotein (patient information)|Patient information]]
|-
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
Line 17: Line 24:
|-  
|-  
!
!
|- bgcolor="Pink"
!
[[High density lipoprotein historical perspective|Historical Perspective]]
|-
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
Line 22: Line 36:
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[High density lipoprotein pathophysiology|Pathophysiology]]
[[High density lipoprotein biochemistry|Biochemistry]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[High density lipoprotein causes|Causes]]
[[High density lipoprotein physiology|Physiology]]
|-
!
 
|- bgcolor="CornFlowerBlue"
!
Clinical Correlation
|-  
|-  
!
!
|- bgcolor="Pink"
 
|- bgcolor="LightSkyBlue"
!
!
[[High density lipoprotein epidemiology and demographics|Epidemiology and Demographics]]
[[High HDL|High HDL]]
: [[High HDL epidemiology and demographics|Epidemiology and Demographics]]
: [[High HDL pathophysiology|Pathophysiology]]
: [[High HDL causes|Causes]]
: [[High HDL diseases|Diseases]]
: [[High HDL prognosis and complications|Prognosis and Complications]]
|-  
|-  
!
!
|- bgcolor="Pink"
 
|- bgcolor="LightSkyBlue"
!
!
[[High density lipoprotein low HDL and cardiovascular risk|Low HDL and Cardiovascular Risk]]
[[Low HDL|Low HDL]]
: [[Low HDL epidemiology and demographics|Epidemiology and Demographics]]
: [[Low HDL pathophysiology|Pathophysiology]]
: [[Low HDL causes|Causes]]
: [[Low HDL diseases|Diseases]]
: [[Low HDL prognosis and complications|Prognosis and Complications]]
|-  
|-  
!
!
|- bgcolor="CadetBlue"
|- bgcolor="CadetBlue"
!
!
Line 47: Line 82:
|-  
|-  
!
!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[High density lipoprotein landmark trials|Landmark Trials]]
[[High density lipoprotein medical therapy|Medical Therapy]]
|-  
|-  
!
!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[High density lipoprotein secondary prevention|Secondary Prevention]]
[[High density lipoprotein primary prevention| Primary Prevention]]
|-  
|-  
!
|- bgcolor="PaleTurquoise"
!
!
[[High density lipoprotein secondary prevention| Secondary Prevention]]
|-
!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[High density lipoprotein cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[High density lipoprotein landmark trials|Landmark Trials]]
|-  
|-  
!  
!
 
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[High density lipoprotein future or investigational therapies|Future or Investigational Therapies]]
[[High density lipoprotein future or investigational therapies|Future or Investigational Therapies]]
|-  
|-  
!  
!
|- bgcolor="CadetBlue"
!
Case Studies
|-
!
 
|- bgcolor="PaleTurquoise"
!
[[High density lipoprotein case study one|Case #1]]
|-
!
|- bgcolor="PaleGoldenrod "
|- bgcolor="PaleGoldenrod "
!
!
Line 72: Line 128:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 77: Line 134:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 82: Line 140:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 87: Line 146:
|-  
|-  
!
!
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 92: Line 152:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 97: Line 158:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 102: Line 164:
|-  
|-  
!
!
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 112: Line 175:
|-  
|-  
!
!
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 117: Line 181:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 122: Line 187:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 127: Line 193:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 132: Line 199:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 137: Line 205:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 142: Line 211:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 147: Line 217:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 152: Line 223:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 157: Line 229:
|-  
|-  
!  
!  
|}
|}

Revision as of 16:23, 12 September 2013

High density lipoprotein Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Biochemistry

Physiology

Clinical Correlation

High HDL

Epidemiology and Demographics
Pathophysiology
Causes
Diseases
Prognosis and Complications

Low HDL

Epidemiology and Demographics
Pathophysiology
Causes
Diseases
Prognosis and Complications

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Landmark Trials

Future or Investigational Therapies

Case Studies

Case #1

High density lipoprotein On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of High density lipoprotein

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on High density lipoprotein

CDC on High density lipoprotein

High density lipoprotein in the news

Blogs on High density lipoprotein

Directions to Hospitals Treating High density lipoprotein

Risk calculators and risk factors for High density lipoprotein

Retrieved from "https://www.wikidoc.org/index.php?title=Template:High_density_lipoprotein&oldid=904545"